Metabolites of monoamines in urine and cerebrospinal fluid, after large dose amphetamine administration.
D000588:Amines / Q000134:cerebrospinal fluid / Q000378:metabolism* / Q000652:urine; D000661:Amphetamine / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D006018:Glycols / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid / Q000652:urine; D008297:Male; D010468:Perceptual Disorders / Q000139:chemically induced; D010648:Phenylacetates / Q000134:cerebrospinal fluid / Q000652:urine; D019966:Substance-Related Disorders; D014642:Vanilmandelic Acid / Q000134:cerebrospinal fluid / Q000652:urine
D000588:Amines; D006018:Glycols; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D000661:Amphetamine